Table 1 Baseline demographic and laboratory measurements by treatment allocation

 Age at randomization (years)^a

62 (12)

62 (12)

 Men

2915 (63%)

2885 (62%)

  White

3332 (72%)

3314 (72%)

  Black

137 (3%)

127 (3%)

  Chinese

557 (12%)

563 (12%)

  Other Asian

486 (10%)

480 (10%)

  Other/not specified

138 (3%)

136 (3%)

 Prior vascular disease^a

711 (15%)

682 (15%)

 Diabetes^a

1054 (23%)

1040 (23%)

  On dialysis^a

1534 (33%)

1491 (32%)

   Haemodialysis

1275 (27%)

1253 (27%)

   Peritoneal dialysis

259 (6%)

238 (5%)

  Not on dialysis^a

3116 (67%)

3129 (68%)

 Total cholesterol (mmol/L)^a

4.88 (1.20)

4.90 (1.17)

 LDL cholesterol (mmol/L)^a

2.77 (0.88)

2.78 (0.87)

 HDL cholesterol (mmol/L)^a

1.12 (0.35)

1.11 (0.34)

 Triglycerides (mmol/L)^a

2.31 (1.76)

2.34 (1.68)

 Body mass index (kg/m²)^a

27.1 (5.7)

27.1 (5.6)

 MDRD-estimated GFR (mL/min/1.73 m²)^a,b,c

26.6 (12.9)

26.6 (13.1)

  ≥60

44 (1%)

44 (1%)

  ≥30 to <60

1100 (37%)

1055 (35%)

  ≥15 to <30

1246 (41%)

1319 (44%)

   < 15

613 (20%)

606 (20%)

  Not available

113

105